Azane;4,4-dimethyl-2-(3-morpholin-4-ylphenyl)-6-propan-2-yl-2,3-dihydroquinoline-1-carboxylic acid
C25H35N3O3 — CID 66587751
Data last refreshed: (MolForge compound catalog, from PubChem)
About Azane;4,4-dimethyl-2-(3-morpholin-4-ylphenyl)-6-propan-2-yl-2,3-dihydroquinoline-1-carboxylic acid
Azane;4,4-dimethyl-2-(3-morpholin-4-ylphenyl)-6-propan-2-yl-2,3-dihydroquinoline-1-carboxylic acid (PubChem CID 66587751) has the molecular formula C25H35N3O3 and a molecular weight of 425.57 g/mol. Its IUPAC name is azane;4,4-dimethyl-2-(3-morpholin-4-ylphenyl)-6-propan-2-yl-2,3-dihydroquinoline-1-carboxylic acid.
Molecular Properties
| Compound Name | Azane;4,4-dimethyl-2-(3-morpholin-4-ylphenyl)-6-propan-2-yl-2,3-dihydroquinoline-1-carboxylic acid |
|---|---|
| PubChem CID | 66587751 |
| Molecular Formula | C25H35N3O3 |
| Molecular Weight | 425.57 g/mol |
| Exact Mass | 425.27 |
| IUPAC Name | azane;4,4-dimethyl-2-(3-morpholin-4-ylphenyl)-6-propan-2-yl-2,3-dihydroquinoline-1-carboxylic acid |
| SMILES | CC(C)c1ccc2c(c1)C(C)(C)CC(c1cccc(N3CCOCC3)c1)N2C(=O)O.N |
| InChI | InChI=1S/C25H32N2O3.H3N/c1-17(2)18-8-9-22-21(15-18)25(3,4)16-23(27(22)24(28)29)19-6-5-7-20(14-19)26-10-12-30-13-11-26;/h5-9,14-15,17,23H,10-13,16H2,1-4H3,(H,28,29);1H3 |
| InChIKey | XFRXHEXNVDMQDC-UHFFFAOYSA-N |
| XLogP | 5.72 |
| TPSA | 88.01 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.57 |
| LogP ≤ 5 | 5.72 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66587751 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.